0
     

Report Added
Report already added
South and Central America In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

South and Central America In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

The in-vitro diagnostics market in South and Central America is expected to grow from US$ 4,387.7 million in 2019 to US$ 5,820.0 million by 2027; it is estimated to grow at a CAGR of 3.6% from 2020 to 2027. Automation deals with the utilization of various intelligent systems with an aim to perform any operation with minimal human intervention. The application of automation in clinical laboratories enables analysts to perform several tests in minimum turnaround time and efforts. Moreover, the automation can serve maximum accuracy in results as well as reduction in variations. Additionally, installation of intelligent software & hardware in clinical analyzers has dramatically improved the overall operating capacity, quality of data processing, and process control in clinical automation. Extensively increasing patient pool is generating massive demand for clinical automation as it offers superior benefits. For instance, in May 2019, Beckman Coulter, one of the major market players announced introduction of its new DxA 5000 total laboratory automation solution. The newly launched system is capable of managing high volume samples with significant reduction in procedural time. Furthermore, growing emphasis of healthcare institutes on cost and time optimization is fueling the adoption of automation in clinical laboratories. Additionally, increasing focus on error reduction, efficient sample collection, and patient safety would eventually boost the acceptance of laboratory automation during the forecast period.

The South and Central America in-vitro diagnostics market is segmented on the basis of product and services, technology, application, and end user. Based on product and services, the market is segmented into reagents and kits, instruments, and software and services. In 2019, the instruments and kits segment accounted for the largest market share. The market for the instruments and kits segment is expected to grow during the forecast period owing to the increasing adoption of in-vitro diagnostics across the region. Moreover, factors such as the increasing prevalence of chronic diseases coupled with growing awareness and availability of the product in considerable margins are projected to drive the market growth for the instruments and kits segment during the forecast period.

In South and Central America, countries such as Brazil, Chile, and Peru have reported the significant incidence of COVID-19 patients. According to the Pan American Health Organization (PAHO), as of June 12, 2020, Brazil, Peru, and Chile had 5.1%, 2.8%, and 1.8% crude case fatality rates (CFR), respectively. Maximum deaths were recorded in the age group of 60–70 years and above. In addition. 60% of these deaths occurred in this age group was of men. Therefore, the rise in the incidence demands IVD test kits and products. The biotechnology industry is growing in the countries, which is to offer lucrative opportunities for the South and Central America in-vitro diagnostics market in the coming years.

The overall South and Central America in-vitro diagnostics market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast for the South and Central America in-vitro diagnostics market with respect to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the South and Central America in-vitro diagnostics market. F. HOFFMANN-LA ROCHE LTD.; DANAHER; ABBOTT; SIEMENS AG; SYSMEX CORPORATION; THERMO FISHER SCIENTIFIC, INC.; BD; BIOMERIEUX SA; BIO-RAD LABORATORIES, INC.; and QIAGEN are among the players operating in the market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 In-Vitro Diagnostics Market – By Product and Services
1.3.2 In-Vitro Diagnostics Market – By Technology
1.3.3 In-Vitro Diagnostics Market – By Application
1.3.4 In-Vitro Diagnostics Market – By End User
1.3.5 South and Central America In-Vitro Diagnostics Market – By Country
2. South and Central America In-Vitro Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America In-Vitro Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 In-Vitro Diagnostics Market- South and Central America PEST Analysis
4.3 Expert Opinion
5. South and Central America In-Vitro Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
5.1.2 Growing Geriatric Population
5.1.3 Rising Demand for In-Vitro Diagnostics During COVID-19 Pandemic
5.2 Market Restraints
5.2.1 Lack of Healthcare Infrastructure and Reimbursement Policies
5.3 Future Trends
5.3.1 Increasing Adoption and Popularity of Automation in Clinical Laboratories
5.4 Impact Analysis
6. In-Vitro Diagnostics Market – South and Central America Analysis
6.1 South and Central America In-Vitro Diagnostics Market Revenue Forecasts and Analysis
7. South and Central America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Product and Services
7.1 Overview
7.2 In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)
7.3 Reagents & Kits
7.3.1 Overview
7.3.2 Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services Market Revenue and Forecast to 2027 (US$ Mn)
8. South and Central America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Technology
8.1 Overview
8.2 In-Vitro Diagnostics Market, by Technology, 2019 & 2027 (% Share)
8.3 Immunoassay/Immunochemistry
8.3.1 Overview
8.3.2 Immunoassay/Immunochemistry Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Clinical Chemistry
8.4.1 Overview
8.4.2 Clinical Chemistry Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Molecular Diagnostics
8.5.1 Overview
8.5.2 Molecular Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Microbiology
8.6.1 Overview
8.6.2 Microbiology Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Blood Glucose Self-Monitoring
8.7.1 Overview
8.7.2 Blood Glucose Self-Monitoring Market Revenue and Forecast to 2027 (US$ Mn)
8.8 Coagulation and Hemostasis
8.8.1 Overview
8.8.2 Coagulation and Hemostasis Market Revenue and Forecast to 2027 (US$ Mn)
8.9 Haematology
8.9.1 Overview
8.9.2 Haematology Market Revenue and Forecast to 2027 (US$ Mn)
8.10 Urinalysis
8.10.1 Overview
8.10.2 Urinalysis Market Revenue and Forecast to 2027 (US$ Mn)
8.11 Others
8.11.1 Overview
8.11.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
9. South and Central America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Application
9.1 Overview
9.2 In-Vitro Diagnostics Market, by Application, 2019 & 2027 (% Share)
9.3 Infectious Diseases
9.3.1 Overview
9.3.2 Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Diabetes
9.4.1 Overview
9.4.2 Diabetes Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Cardiology
9.6.1 Overview
9.6.2 Cardiology Market Revenue and Forecast to 2027 (US$ Mn)
9.7 Autoimmune Disease
9.7.1 Overview
9.7.2 Autoimmune Disease Market Revenue and Forecast to 2027 (US$ Mn)
9.8 Nephrology
9.8.1 Overview
9.8.2 Nephrology Market Revenue and Forecast to 2027 (US$ Mn)
9.9 Others
9.9.1 Overview
9.9.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
10. South and Central America In-Vitro Diagnostics Market Analysis and Forecasts to 2027– By End user
10.1 Overview
10.2 In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Laboratories
10.4.1 Overview
10.4.2 Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
10.5 Homecare
10.5.1 Overview
10.5.2 Homecare Market Revenue and Forecast to 2027 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
11. In-Vitro Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis
11.1 South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027
11.1.1 South and Central America In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)
11.1.2 Brazil
11.1.2.1 Brazil In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
11.1.2.1.1 Brazil In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)
11.1.2.1.2 Brazil In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)
11.1.2.1.3 Brazil In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)
11.1.2.1.4 Brazil In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)
11.1.3 Argentina
11.1.3.1 Argentina In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
11.1.3.1.1 Argentina In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)
11.1.3.1.2 Argentina In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)
11.1.3.1.3 Argentina In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)
11.1.3.1.4 Argentina In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)
11.1.4 Rest of South and Central America
11.1.4.1 Rest of South and Central America In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
11.1.4.1.1 Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)
11.1.4.1.2 Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)
11.1.4.1.3 Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)
11.1.4.1.4 Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)
12. Impact Of COVID-19 Pandemic on South and Central America In-Vitro Diagnostics Market
12.1 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Organic Developments Done by The Companies in The Market
13.3 Inorganic Developments Done by The Companies in The Market
14. COMPANY PROFILES
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Danaher
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Siemens AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Sysmex Corporation
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 THERMO FISHER SCIENTIFIC INC.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 BD
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 bioMerieux SA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 QIAGEN
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms

Table 1. Key launches 2016: By Roche
Table 2. Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)
Table 3. Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 4. Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)
Table 5. Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)
Table 6. Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)
Table 7. Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 8. Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)
Table 9. Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)
Table 10. Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)
Table 11. Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 12. Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)
Table 13. Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)
Table 14. Organic Developments Done by The Companies
Table 15. Inorganic Developments Done by The Companies
Table 16. Glossary of Terms, In-Vitro Diagnostics Market

Figure 1. In-Vitro Diagnostics Market Segmentation
Figure 2. South and Central America In-Vitro Diagnostics Market Overview
Figure 3. Reagents and Kits Segment Held Largest Share of Product and Services in In-Vitro Diagnostics Market
Figure 4. Infectious Diseases Segment Held Largest Share of Application in In-Vitro Diagnostics Market
Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. In-Vitro Diagnostics Market - South and Central America PEST Analysis
Figure 7. In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints
Figure 8. South and Central America In-Vitro Diagnostics Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)
Figure 10. Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)
Figure 11. Instruments Market Revenue and Forecast to 2027 (US$ Mn)
Figure 12. Software & Services Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13. In-Vitro Diagnostics Market, By Technology, 2019 & 2027 (% Share)
Figure 14. Immunoassay/Immunochemistry Market Revenue And Forecast To 2027 (US$ Mn)
Figure 15. Clinical Chemistry Market Revenue And Forecast To 2027 (US$ Mn)
Figure 16. Molecular Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)
Figure 17. Microbiology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 18. Blood Glucose Self-Monitoring Market Revenue And Forecast To 2027 (US$ Mn)
Figure 19. Coagulation and Hemostasis Market Revenue And Forecast To 2027 (US$ Mn)
Figure 20. Hematology Market Revenue and Forecast to 2027 (US$ Mn)
Figure 21. Urinalysis Market Revenue And Forecast To 2027 (US$ Mn)
Figure 22. Others Market Revenue And Forecast To 2027 (US$ Mn)
Figure 23. In-Vitro Diagnostics Market, By Application, 2019 & 2027 (% Share)
Figure 24. Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 25. Diabetes Market Revenue And Forecast To 2027 (US$ Mn)
Figure 26. Most Prevalent Forms of Cancers Globally, 2018
Figure 27. Oncology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 28. Cardiology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 29. Autoimmune Disease Market Revenue And Forecast To 2027 (US$ Mn)
Figure 30. Nephrology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 31. Others Market Revenue And Forecast To 2027 (US$ Mn)
Figure 32. In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)
Figure 33. Hospitals Market Revenue And Forecast To 2027 (US$ Mn)
Figure 34. Laboratories Market Revenue And Forecast To 2027 (US$ Mn)
Figure 35. Homecare Market Revenue And Forecast To 2027 (US$ Mn)
Figure 36. Others Market Revenue and Forecast to 2027 (US$ Mn)
Figure 37. South and Central America In-Vitro Diagnostics Market Revenue, By Country, 2019 (US$ Mn)
Figure 38. South and Central America In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)
Figure 39. Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)
Figure 40. Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)
Figure 41. Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)
Figure 42. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 43. Growth Strategies Done by the Companies in the Market, (%)

Report Title: South and Central America In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline